Patients with SSc vs controls showed a greater prevalence of WMH on brain MRIs, particularly in deep white matter regions.

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

Clinical trial timelines for key lymphoma and autoimmune disease programs were delayed by approximately two quarters. Cash and investments totaled $302.6 million at the end of Q2 2025, expected to ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

Novartis announces positive results from VAYHIT2 phase III trial of ianalumab plus eltrombopag in patients with primary immune thrombocytopenia: Basel Wednesday, August 13, 2025, ...

Initial update for NKX019 in multiple autoimmune indications expected in second half of 2025Cash balance of $334.0 million on June 30, 2025, including cash, cash equivalents and investments, expected ...

GAAP revenue was $2.7 million for Q2 2025, missing analyst estimates by 20.6%. Operating expenses surged, driven by costs tied to the ACELYRIN merger and clinical trial acceleration. The merger ...

Alumis continues to leverage its proprietary data analytics and research platform to advance discovery programs that target key drivers of immune-mediated diseases. In addition to its two ...

Unexplained tingling, known to doctors as paresthesia, is often only temporary and harmless. But it can be a symptom of ...

Zenas BioPharma, Inc. ( ($ZBIO) ) has released its Q2 earnings. Here is a breakdown of the information Zenas BioPharma, Inc. presented to its ...

Autolus Therapeutics ( ($AUTL) ) has released its Q2 earnings. Here is a breakdown of the information Autolus Therapeutics presented to its ...

Join us for an uplifting and insightful episode of the Caregiver Relief Podcast with special guest Janet Kuebler, a certified ...